EUVIMEDEUVIMED entdecken
Open Access

Nitric Oxide Conjugation Transforms NIR‐II AIEgens Into Potent Hypoxia‐Tolerant Type I Photosensitizers

Junjun Ni, Yan Feng iD, Jianquan Zhang iD, Muhammad Muazzam Naseer, Liang Guo iD, Kunpeng Feng, Ryan T K Kwok iD, Jacky W Y Lam, Lianrui Hu, Xiaoran Yin, Guorui Jin, Ben Zhong Tang iD

Advanced Materials · 2026

DOI: 10.1002/adma.73860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Junjun Ni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineeri…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Nitric Oxide, Infrared Rays. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key R&D Program of Shaanxi Province, Key Medical Research Project of Xi'an Science and Technology Plan, Key Projects of the Xiangyang Innovation and Development Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Near‐infrared (NIR)‐activated type I photosensitizers (PSs) with aggregation‐induced emission (AIE) properties are highly attractive for photodynamic therapy (PDT) of deep‐seated and inoperable tumors. However, most NIR‐activated AIEgens, especially donor–acceptor–donor (D‐A‐D) benzobisthiadiazole derivatives, are mainly used for bioimaging and photothermal therapy due to their intrinsically small S 1 →S 0 energy gaps (Δ E S1‐S0 ) severely limiting reactive oxygen species (ROS) generation. Here, we present a strategy to convert widely adopted D‐A‐D NIR‐activated AIEgens into NIR‐activated type I PSs by conjugating nitric oxide (NO) to the electron‐donating units. Upon NO conjugation, the resulting compounds NO‐T‐TQT and NO‐2TT‐ o C6B become efficient generators of NIR‐activated hydroxyl radical (•OH), exhibiting a 13.2‐fold and 5.4‐fold increase in superoxide (O 2 •− ) production compared with their parent molecules, respectively. In contrast, T‐TQT, 2TT‐ o C6B, and related analogues produce negligible ROS and no detectable •OH. Mechanistic studies reveal that NO conjugation narrows the singlet‐triplet energy gap, strengthens spin‐orbit coupling to enhance intersystem crossing, optimizes redox potentials to favor electron transfer, and lowering hydrogen atom affinity. NO‐2TT‐ o C6B nanoparticles achieved potent in vitro cytotoxicity and effective in vivo tumor ablation under NIR irradiation. This work establishes a general approach to transform conventional NIR‐activated D‐A‐D AIEgens into high‐performance type I PSs, significantly advancing their clinical potential in PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsNitric OxideInfrared RaysAnimalsHumansReactive Oxygen SpeciesThiadiazolesPhotochemotherapyMiceCell Line, Tumor

Stichwörter der Autor:innen

NIR‐II fluorescenceaggregation‐induced emissionhypoxia‐tolerant photodynamic therapynitric oxidetype I photosensitizer

Substanzen

Photosensitizing AgentsNitric OxideReactive Oxygen SpeciesThiadiazoles

Autor:innen und Institutionen

  • Bioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. C…
  • Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China.
  • Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, P…
  • Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Division of Life Science, State Key Laboratory of Nervous System Disorders, and Depart…
  • Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Frontiers Science Center of Molecule Intelligent Syntheses, School of Chemistry and Molecular Engineering, East China Nor…

ORCID-Profile: Yan Feng, Jianquan Zhang, Liang Guo, Ryan T K Kwok, Ben Zhong Tang

Förderung

  • Key R&D Program of Shaanxi Province
  • Key Medical Research Project of Xi'an Science and Technology Plan
  • Key Projects of the Xiangyang Innovation and Development Joint Fund
  • Natural Science Foundation of Hubei Province
  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Guangdong Basic Research Center of Excellence for Aggregate Science
  • Science, Technology and Innovation Commission of Shenzhen Municipality

Zitieren

APA

Ni, J., Feng, Y., Zhang, J., Naseer, M. M., Guo, L., Feng, K., Kwok, R. T. K., Lam, J. W. Y., Hu, L., Yin, X., Jin, G., & Tang, B. Z. (2026). Nitric Oxide Conjugation Transforms NIR‐II AIEgens Into Potent Hypoxia‐Tolerant Type I Photosensitizers. Advanced Materials. https://doi.org/10.1002/adma.73860

Vancouver

Ni J, Feng Y, Zhang J, Naseer MM, Guo L, Feng K, et al. Nitric Oxide Conjugation Transforms NIR‐II AIEgens Into Potent Hypoxia‐Tolerant Type I Photosensitizers. Advanced Materials. 2026. doi:10.1002/adma.73860

BibTeX
@article{Ni2026,
  author = {Ni, Junjun and Feng, Yan and Zhang, Jianquan and Naseer, Muhammad Muazzam and Guo, Liang and Feng, Kunpeng and Kwok, Ryan T K and Lam, Jacky W Y and Hu, Lianrui and Yin, Xiaoran and Jin, Guorui and Tang, Ben Zhong},
  title = {Nitric Oxide Conjugation Transforms NIR‐II AIEgens Into Potent Hypoxia‐Tolerant Type I Photosensitizers},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.73860}
}
Kostenlos starten →